Oncology Institute Inc (NASDAQ: TOI) kicked off on Tuesday, down -7.48% from the previous trading day, before settling in for the closing price of $3.21. Over the past 52 weeks, TOI has traded in a range of $0.13-$3.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -488.57% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 34.51%. With a float of $45.65 million, this company’s outstanding shares have now reached $88.93 million.
In an organization with 825 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 14.7%, operating margin of -12.91%, and the pretax margin is -15.96%.
Oncology Institute Inc (TOI) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of Oncology Institute Inc is 50.33%, while institutional ownership is 14.85%. The most recent insider transaction that took place on Jun 05 ’25, was worth 2,054,712. In this transaction Director of this company sold 673,676 shares at a rate of $3.05, taking the stock ownership to the 13,950,557 shares. Before that another transaction happened on Jun 05 ’25, when Company’s Director sold 76,324 for $3.05, making the entire transaction worth $232,788. This insider now owns 1,272,724 shares in total.
Oncology Institute Inc (TOI) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.51% per share during the next fiscal year.
Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators
Take a look at Oncology Institute Inc’s (TOI) current performance indicators. Last quarter, stock had a quick ratio of 1.59. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.70, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of Oncology Institute Inc (TOI)
Let’s dig in a bit further. During the last 5-days, its volume was 2.9 million. That was better than the volume of 1.35 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 84.71%.
During the past 100 days, Oncology Institute Inc’s (TOI) raw stochastic average was set at 81.71%, which indicates a significant increase from 72.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was lower than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.71, while its 200-day Moving Average is $1.23. However, in the short run, Oncology Institute Inc’s stock first resistance to watch stands at $3.16. Second resistance stands at $3.34. The third major resistance level sits at $3.45. If the price goes on to break the first support level at $2.87, it is likely to go to the next support level at $2.76. Assuming the price breaks the second support level, the third support level stands at $2.58.
Oncology Institute Inc (NASDAQ: TOI) Key Stats
The company with the Market Capitalisation of 272.98 million has total of 89,234K Shares Outstanding. Its annual sales at the moment are 393,410 K in contrast with the sum of -64,660 K annual income. Company’s last quarter sales were recorded 104,410 K and last quarter income was -19,590 K.
